NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells

NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells

(2017) Ya Zhou et al.   Oncotarget

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer

(2017) Omar Elaskalani et al.   World Journal of Gastrointestinal Oncology

LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1

(2017) Bei Wang et al.   PLoS One

Direct interaction between miR-203 and ZEB2 suppresses epithelial–mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance

(2016) Xunhuang Duan et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Global Incidence and Mortality Rates of Stomach Cancer and the Human Development Index: an Ecological Study

(2016) Salman Khazaei et al.   Asian Pacific Journal of Cancer Prevention

Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer

(2016) Xin Yong et al.   CANCER LETTERS

Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement

(2016) Rashmi Bharti et al.   CANCER LETTERS

Insights into the Nanog gene: A propeller for stemness in primitive stem cells

(2016) Wei Zhang et al.   International Journal of Biological Sciences

Proton pump inhibitor pantoprazole inhibits the proliferation, self-renewal and chemoresistance of gastric cancer stem cells via the EMT/β-catenin pathways

(2016) Shuitu Feng et al.   ONCOLOGY REPORTS

IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer

(2016) Chao Yao et al.   STEM CELLS

Expression of stem cell markers nanog and PSCA in gastric cancer and its significance

(2015) XUANZHONG ZHAO et al.   Oncology Letters

In vivo reprogrammed pluripotent stem cells from teratomas share analogous properties with their in vitro counterparts

(2015) Hyun Woo Choi et al.   Scientific Reports

Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts

(2015) Dominique M. Higgins et al.   Oncotarget

On the Origin and Evolutionary History of NANOG

(2014) Pierluigi Scerbo et al.   PLoS One

COX-2 Inhibitors and Gastric Cancer

(2014) Zhen Wang et al.   Gastroenterology Research and Practice

Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1α expression is involved in prostate epithelial malignancy

(2014) KATSUHITO MIYAZAWA et al.   Oncology Letters

Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells

(2013) Yuhua Lu et al.   CANCER LETTERS

Emerging role of nanog in tumorigenesis and cancer stem cells

(2013) Luis E. IV Santaliz-Ruiz et al.   INTERNATIONAL JOURNAL OF CANCER

RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway

(2013) Jiang Cao et al.   LEUKEMIA RESEARCH

Coexpression of Stemness Factors Oct4 and Nanog Predict Liver Resection

(2012) Xin Yin et al.   ANNALS OF SURGICAL ONCOLOGY

Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State

(2012) Wenjun Guo et al.   CELL

Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells

(2012) Keita Uchino et al.   EXPERIMENTAL CELL RESEARCH

Expression of Wnt3 Activates Wnt/ -Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells

(2012) Y. Wu et al.   MOLECULAR CANCER RESEARCH

Embryonic NANOG Activity Defines Colorectal Cancer Stem Cells and Modulates through AP1- and TCF-dependent Mechanisms

(2012) Elsayed E. Ibrahim et al.   STEM CELLS

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling

(2011) Andrei Glinka et al.   EMBO REPORTS

Novel Double-negative Feedback Loop between Adenomatous Polyposis Coli and Musashi1 in Colon Epithelia

(2011) Erick Spears et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma

(2011) Ting Lin et al.   MEDICAL ONCOLOGY

ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy

(2010) Xi-wei Ding et al.   LIFE SCIENCES

Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia

(2010) Michael G Kharas et al.   NATURE MEDICINE

Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells

(2010) Irina Eberle et al.   NUCLEIC ACIDS RESEARCH

The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development

(2010) JINGYU ZHANG et al.   Oncology Letters

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression

(2008) Elizabeth Vincan et al.   CLINICAL & EXPERIMENTAL METASTASIS

Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling

(2008) Ilaria Malanchi et al.   NATURE